Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · P060019/S058

Cool Point Tubing Set

Irvine Biomedical, Inc. · Decision date Dec 19, 2025

FDA DECISIONP060019/S058

What did the FDA decide?

FDA records P060019/S058 as a supplement to PMA P060019, with the supplement type “30-Day Notice”. The recorded decision is OK30 (30-day notice), dated Dec 19, 2025.

FDA approval order statement

changes in polycarbonate resins, adhesives, and luers with minor dimensional changes
Regulatory pathway
PMA supplement
Supplement type
30-Day Notice
Clinical specialty
Cardiovascular
Decision date
Dec 19, 2025
FDA change category
Process Change - Manufacturer/Sterilizer/Packager/Supplier

FDA source record

Regulatory record facts

Identifier
P060019/S058
Regulatory pathway
PMA supplement
Product code
OAD
Decision code
OK30
Decision date
Dec 19, 2025
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: catheter, percutaneous, cardiac ablation, for treatment of atrial flutter.

Product code
OAD
FDA device class
3

Review the original FDA PMA listing for the original approval scope and linked supplements.

FDA decision timeline

  1. P060019/S058 received

    Application receipt date recorded by FDA.

  2. P060019/S058 · FDA decision

    30-Day Notice

Timeline entries are records held by MedtechLedger for P060019. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P060019

Product / regulatory recordCompanyPathwayDecision dateSource
Ampere GeneratorP060019/S059
Irvine Biomedical, Inc.PMA supplementAug 7, 2026FDA

Explore the linked device profile

Other records with product code OAD

Product / regulatory recordCompanyPathwayDecision dateSource
Biosense Webster, Inc.PMA supplementSep 15, 2026FDA
Irvine Biomedical,Inc.(Ibi)PMA supplementSep 3, 2026FDA
Biosense Webster, Inc.PMA supplementSep 2, 2026FDA
Ampere GeneratorP040042/S059
Irvine Biomedical,Inc.(Ibi)PMA supplementAug 7, 2026FDA
Ampere GeneratorP110016/S095
ABBOTT MEDICALPMA supplementAug 7, 2026FDA

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Irvine Biomedical, Inc.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
2375 Morse Ave., Irvine, CA, 92614

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records